Micron Biomedical

Micron Biomedical

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://www.micronbiomedical.com

Last Round

Series A

Extension

Jan 16, 2025

Total Funding Raised

$75.3M

Momentum Score

50 /100

Company Overview

Micron Biomedical is a biopharmaceutical company that develops a proprietary dissolvable microarray patch technology for needle-free delivery of vaccines and therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Pharma Supply Chain

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

dissolvable microarraymicroneedle patchneedle-free deliveryvaccine patchdrug delivery platformvaccine deliverythermostable vaccineself-administered vaccinecold chain reductionclinical-stage biotechtransdermal drug deliverymRNA vaccine deliveryglobal health technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Micron Biomedical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Micron Biomedical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 16, 2025
GrantJan 8, 2025
GrantJan 7, 2025
GrantJan 7, 2025
GrantNov 16, 2023
Series A
May 10, 2023

Key People

Founding team and executive leadership

Devin McAllister

EVP, CTO Co-Founder

Founding Team

Steven Damon

Chief Executive Officer

Executive Team

Micron Biomedical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2026

    Recognized as highest global priority innovation by VIPS Alliance.

  • Jan 1, 2026

    Named to Fast Company's 2026 World's Most Innovative Companies list.

Micron Biomedical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Micron Biomedical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Micron Biomedical's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range25
Year Founded2014
Last FundingJan 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.